FDA
-
-
-
-
-
-
-
Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCare™ (a Competitor of Prilosec® OTC)
-
-
-
-
-
-
-
Innovus Pharma Announces Initiation of a Clinical Study to Evaluate the Tolerance and the Effect of Musclin™ on Muscle Health in Adults in the United States
-
-
-
-
-
-
-
Innovus Pharma Announces the Launch of its Hemorrhoid Drug Xyralid® in Canada
-
-
-
-
-
-
-
Innovus Pharma Announces U.S. Food and Drug Administration Clearance of Its UriVarx® Urinary Tract Infection Test Strips
-
-
-
-
-
-
-
Innovus Pharma Announces Combined Launch of Apeaz™ Cream for Arthritis Pain Relief, and ArthriVarx™, a Supplement Designed to Maximize and Support Joint Health
-
-
-
-
-
-
-
Innovus Pharmaceuticals Announces $3.85 Million Public Offering
-
332,173 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

